ALI ALTAHIR: Open Payments
NPI 1760506687 · STAFFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 14 payments from 7 companies in 2025. Trend: 2023 $176 · 2024 $498 · 2025 $1,627
Debt forgiveness: $1,360Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $1,360 |
| Collegium Pharmaceutical, Inc. | 5 | $115 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Corium, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, Jornay PM, Qelbree, SPRAVATO, CAPLYTA, Azstarys, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
